GILD — Gilead Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Gilead Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,408	6,520	6,385	7,264	9,991
Net Total Accounts Receivable
Net Total Receivables	4,892	4,493	4,777	4,660	4,420
Total Inventory
Prepaid Expenses
Total Current Assets	15,996	14,772	14,443	16,085	19,173
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,613	5,663	5,475	5,317	5,414
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	68,407	67,952	63,171	62,125	58,995
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,397	11,610	11,237	11,280	12,004
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	50,205	46,883	41,931	39,292	39,665
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	18,202	21,069	21,240	22,833	19,330
Total Liabilities & Shareholders' Equity	68,407	67,952	63,171	62,125	58,995
Total Common Shares Outstanding